Pioneering better health outcomes for those in need by harnessing the power of therapeutic cannabis.
Based in Sydney, Australia, Cannim was established in 2017 to bring the benefits of medicinal cannabis to the world.
Back in 2017, Cannabis was still stigmatised and cultivation considered an art form. Built on the 3 core pillars of Safety, Science, and Scale, Cannim established an organisation that could show people that Cannabis was a real medicine, consistently develop it to pharmaceutical standards, and establish networks to reach a wide audience of needy people.
Just 4 years later, Cannim cultivates in Jamaica and Australia, and established a network of EU GMP manufacturers as well as formed alliances in education and healthcare, offering products & services to bring relief in many forms to people across the world.
This industry is nascent and this is only the beginning of the journey to establish Cannabis as a reputable medicine around the world. Cannim continues to create scale in its operations, giving us the ability to meet the needs of the ever-growing body of medicinal cannabis users. Cannim is pioneering the development of the category, creating new ways of administration for patients, leading research and education into the effects of cannabis on a variety of conditions, pioneering its usefulness for others, and ensuring those in need get what they need when they need it at a price that's fair.
Blue Dream
Parents: Blueberry x Haze
American Bred, 
Dutch Genetics
Further National Health-Service Information on